Back to
VANGUARD GROUP INC
NRXP6 quarters
Position history for
VANGUARD GROUP INC's holdings in NRX PHARMACEUTICALS INC
As of its last 13F, for Q4 2025, Vanguard Group held 729,842 shares of NRXP (NRX Pharmaceuticals), worth $2M. It increased the position by 194,886 shares (+36.4%) from Q3 2025. Vanguard Group held NRXP from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$2M
Current Shares
729,842
Total Value Change
+$1.6M
Total Shares Change
+489,526
Quarter-by-Quarter History
Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, BALYASNY ASSET MANAGEMENT L.P., CITADEL ADVISORS LLC